We are revolutionizing production record management systems, traditionally maintained on handwritten paper forms, with current technology.
We are automating the review of biotech's handwritten documents through the use of machine learning and intelligent character recognition (ICR) technology. Our solution creates a seamless transition to paperless electronic batch record (EBR) management by utilizing common documents used on production floors today.
Our unprecedented approach is fully compliant with 21 CFR regulation and enables a new dimension of quality and operational insights for partners.
autoGDP provides the ability to identify and resolve deviations that can impact product quality in real time. Through defined acceptance criteria and process-step parameters, errors are automatically flagged at the time of data entry instead of post-production document review. Transparency is optimized through field history tracking to create a comprehensive audit trail of unique user profiles for each batch record. This provides a full audit record of updates and error corrections in a compliant way.
Structured electronic batch data offers new dimensions of quality control. Real-time trend reporting of critical quality attributes (CQAs) can be utilized to identify the corrective or preventive actions necessary to continually ensure the highest product quality and optimal operating processes.
Data integrity is consistently the top focus of the FDA, international regulatory agencies, and our clients’ quality assurance teams. To ensure superior adherence to federal guidance, autoGDP fully compliant to 21 CFR regulation. All data entries are electronically timestamped, recorded, and are readily available for reporting. Unique user profiles and automated quality checks ensure that the data entered is complete, traceable, and in the correct format.
To ensure conformance to FDA requirements, pharmaceutical, medical device, and consumer product manufacturers currently manually document each step of the batch production process in a batch record. Currently, this is completed through handwritten records that must be manually reviewed for production errors prior to final product release to market.
By utilizing autoGDP’s validated electronic batch record solution, our clients will substantially reduce product release cycle time, automate error detection, and enhance data integrity - all while managing essential documents in an efficient, modern, and reliable way.
Built in accordance with current FDA guidance, autoGDP is designed to meet and exceed 21 CFR part 11, GAMP 5, and ISO 13485 standards. The software provides time-stamped data entries, complete audit trails, e-signature capabilities, and robust security features. We handle the system validation throughout the lifecycle, so our clients can enjoy the full benefits of an electronic batch record without the need of a dedicated IT validation team.
autoGDP’s electronic batch record solution error-proofs key components of data entry and eliminates common production mistakes, such as missing or incomplete documentation, that compound to result in delays to market release. When deviations inevitably occur, our electronic process automatically detects errors to minimize impact to release cycles.
By one competitor survey, electronic batch records decrease the number of days on hold for an equivalent paper-based process by 54%.